As most diseases about liver are concerned with hepatocytes and traditional liposomes just passively target Kupffer cells, the thesis is to study hepatocytes-targeted liposomes, which are modified with asialofetuin (AF) to interact specifically with asial As most diseases about liver are concerned with hepatocytes and traditional liposomes just passively target Kupffer cells, the thesis is to study hepatocytes-targeted liposomes, which are modified with asialofetuin (AF) to interact specifically with asial